Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 50

1.

[Production of a recombinant CagA protein for the detection of Helicobacter pylori CagA antibodies].

Akguc M, Karatayli E, Celik E, Koyuncu D, Celik I, Karatayli SC, Ozden A, Bozdayi AM.

Mikrobiyol Bul. 2014 Jul;48(3):402-12. Turkish.

PMID:
25052106
[PubMed - in process]
Free Article
2.

Free circulating nucleic acids in plasma and serum as a novel approach to the use of internal controls in real time PCR based detection.

Karataylı E, Altunoğlu YC, Karataylı SC, Yurdaydın C, Bozdayı AM.

J Virol Methods. 2014 Jul 14;207C:133-137. doi: 10.1016/j.jviromet.2014.07.008. [Epub ahead of print]

PMID:
25034126
[PubMed - as supplied by publisher]
3.

Tumour necrosis factor-alpha, interleukin-10, interferon-gamma and vitamin D receptor gene polymorphisms in patients with chronic hepatitis delta.

Karatayli SC, Ulger ZE, Ergul AA, Keskin O, Karatayli E, Albayrak R, Ozkan M, Idilman R, Yalcin K, Bozkaya H, Uzunalimoğlu O, Yurdaydin C, Bozdayi AM.

J Viral Hepat. 2014 Apr;21(4):297-304. doi: 10.1111/jvh.12139. Epub 2013 Jul 22.

PMID:
24597698
[PubMed - in process]
4.

A one step real time PCR method for the quantification of hepatitis delta virus RNA using an external armored RNA standard and intrinsic internal control.

Karataylı E, Altunoğlu YÇ, Karataylı SC, Alagöz SG, Cınar K, Yalçın K, Idilman R, Yurdaydın C, Bozdayı AM.

J Clin Virol. 2014 May;60(1):11-5. doi: 10.1016/j.jcv.2014.01.021. Epub 2014 Feb 4.

PMID:
24594080
[PubMed - in process]
5.

Efficacy of tenofovir in adefovir-experienced patients compared to treatment-naive patients with chronic hepatitis B.

Keskin O, Ormeci AC, Baran B, Kabaçam G, Tuzun A, Karatayli E, Akyüz F, Karatayli S, Bozdayi AM, Onel D, Badur S, Idilman R, Kaymakoglu S, Yurdaydin C.

Antivir Ther. 2014 Feb 12. doi: 10.3851/IMP2732. [Epub ahead of print]

PMID:
24517926
[PubMed - as supplied by publisher]
6.

Molecular characterization of hepatitis A virus isolated from acute infections in Turkey.

Dınç B, Koyuncu D, Karatayli SC, Berk E, Karatayli E, Parlak M, Çelık I, Akgüç M, Sertöz R, Berktaş M, Bozdayi G, Bozdayi AM.

Turk J Gastroenterol. 2012;23(6):714-9.

PMID:
23794310
[PubMed - indexed for MEDLINE]
7.

Pegylated interferon-based treatment in patients with advanced liver disease due to chronic delta hepatitis.

Kabaçam G, Dalekos GN, Çakaloğlu Y, Zachou K, Bock T, Erhardt A, Zeuzem S, Tabak F, Yalçin K, Bozdayi AM, Dienes HP, Bozkaya H, Manns M, Wedemeyer H, Yurdaydin C.

Turk J Gastroenterol. 2012;23(5):560-8.

PMID:
23161302
[PubMed - indexed for MEDLINE]
8.

Clonal analysis of the quasispecies of antiviral-resistant HBV genomes in patients with entecavir resistance during rescue treatment and successful treatment of entecavir resistance with tenofovir.

Karatayli E, Idilman R, Karatayli SC, Cevik E, Yakut M, Seven G, Kabaçam G, Bozdayi AM, Yurdaydin C.

Antivir Ther. 2013;18(1):77-85. doi: 10.3851/IMP2294. Epub 2012 Aug 10.

PMID:
22878399
[PubMed - indexed for MEDLINE]
9.

HBeAg-positive hepatitis delta: virological patterns and clinical long-term outcome.

Heidrich B, Serrano BC, Idilman R, Kabaçam G, Bremer B, Raupach R, Önder FO, Deterding K, Zacher BJ, Taranta A, Bozkaya H, Zachou K, Tillmann HL, Bozdayi AM, Manns MP, Yurdaydın C, Wedemeyer H.

Liver Int. 2012 Oct;32(9):1415-25. doi: 10.1111/j.1478-3231.2012.02831.x. Epub 2012 Jun 20.

PMID:
22716112
[PubMed - indexed for MEDLINE]
10.

Entecavir treatment of chronic hepatitis D.

Kabaçam G, Onder FO, Yakut M, Seven G, Karatayli SC, Karatayli E, Savas B, Idilman R, Bozdayi AM, Yurdaydin C.

Clin Infect Dis. 2012 Sep;55(5):645-50. doi: 10.1093/cid/cis459. Epub 2012 May 9.

PMID:
22573857
[PubMed - indexed for MEDLINE]
Free Article
11.

Potential proteomic biomarkers in assessing liver fibrosis using SELDI-TOF MS.

Bozdayi AM, Karatayli SC, Alagöz SG, Mizrak D, Sayki M, Ozkan M, Savaş B, Erden E, Cinar K, Idılman R, Yurdaydin C.

Turk J Gastroenterol. 2012 Feb;23(1):46-53.

PMID:
22505379
[PubMed - indexed for MEDLINE]
12.

Effect of Turkish propolis extracts on proteome of prostate cancer cell line.

Barlak Y, Değer O, Colak M, Karataylı SC, Bozdayı AM, Yücesan F.

Proteome Sci. 2011 Dec 7;9:74. doi: 10.1186/1477-5956-9-74.

PMID:
22152088
[PubMed]
Free PMC Article
13.

Age- and region-specific hepatitis B prevalence in Turkey estimated using generalized linear mixed models: a systematic review.

Toy M, Önder FO, Wörmann T, Bozdayi AM, Schalm SW, Borsboom GJ, van Rosmalen J, Richardus JH, Yurdaydin C.

BMC Infect Dis. 2011 Dec 12;11:337. doi: 10.1186/1471-2334-11-337. Review.

PMID:
22151620
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Molecular characterization of a novel entecavir mutation pattern isolated from a multi-drug refractory patient with chronic hepatitis B infection.

Karatayli E, Karatayli SC, Cinar K, Gokahmetoglu S, Güven K, Idilman R, Yurdaydin C, Bozdayi AM.

J Clin Virol. 2012 Feb;53(2):130-4. doi: 10.1016/j.jcv.2011.10.011. Epub 2011 Nov 9.

PMID:
22078148
[PubMed - indexed for MEDLINE]
15.

Complete genome sequences and phylogenetic analysis of hepatitis delta viruses isolated from nine Turkish patients.

Celik I, Karatayli E, Cevik E, Kabakçi SG, Karatayli SC, Dinç B, Cinar K, Yalçin K, Idilman R, Yurdaydin C, Bozdayi AM.

Arch Virol. 2011 Dec;156(12):2215-20. doi: 10.1007/s00705-011-1120-y. Epub 2011 Oct 5.

PMID:
21984217
[PubMed - indexed for MEDLINE]
16.

Serum connective tissue markers as predictors of advanced fibrosis in patients with chronic hepatitis B and D.

Seven G, Karatayli SC, Köse SK, Yakut M, Kabaçam G, Törüner M, Heper AO, Voelker M, Erden E, Bozdayi AM, Uzunalımoğlu O, Bozkaya H, Yurdaydin C, Schuppan D.

Turk J Gastroenterol. 2011 Jun;22(3):305-14.

PMID:
21805422
[PubMed - indexed for MEDLINE]
17.

Natural history and treatment of chronic delta hepatitis.

Yurdaydın C, Idilman R, Bozkaya H, Bozdayi AM.

J Viral Hepat. 2010 Nov;17(11):749-56. doi: 10.1111/j.1365-2893.2010.01353.x. Epub 2010 Aug 15. Review.

PMID:
20723036
[PubMed - indexed for MEDLINE]
18.

Effects of polymorphism in G2677T/A triallelic region of MDR1 gene in Turkish patients with inflammatory bowel disease.

Sapmaz A, Ozen Karatayli SC, Dağli U, Kiliç ZM, Törüner M, Celik Y, Ozkan M, Soykan I, Cetinkaya H, Ulker A, Ozden A, Bozdayi AM.

Turk J Gastroenterol. 2008 Sep;19(3):168-73.

PMID:
19115152
[PubMed - indexed for MEDLINE]
19.

Treatment of chronic delta hepatitis with lamivudine vs lamivudine + interferon vs interferon.

Yurdaydin C, Bozkaya H, Onder FO, Sentürk H, Karaaslan H, Akdoğan M, Cetinkaya H, Erden E, Erkan-Esin O, Yalçin K, Bozdayi AM, Schinazi RF, Gerin JL, Uzunalimoğlu O, Ozden A.

J Viral Hepat. 2008 Apr;15(4):314-21. doi: 10.1111/j.1365-2893.2007.00936.x.

PMID:
18307594
[PubMed - indexed for MEDLINE]
20.

A pilot study of 2 years of interferon treatment in patients with chronic delta hepatitis.

Yurdaydin C, Bozkaya H, Karaaslan H, Onder FO, Erkan OE, Yalçin K, Değertekin H, Bozdayi AM, Uzunalimoğlu O.

J Viral Hepat. 2007 Nov;14(11):812-6.

PMID:
17927618
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk